These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 39006841)

  • 1. Mesenchymal stem cells preconditioned with a TLR5 agonist enhanced immunoregulatory effect through M2 macrophage polarization in a murine graft-versus-host disease model.
    Gil S; Im KI; Kim N; Lee J; Na H; Min GJ; Cho SG
    Int J Med Sci; 2024; 21(9):1649-1660. PubMed ID: 39006841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.
    Wu R; Liu C; Deng X; Chen L; Hao S; Ma L
    J Cell Mol Med; 2020 Jan; 24(2):1684-1699. PubMed ID: 31782262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel study on the immunomodulatory effect of umbilical cord derived mesenchymal stem cells pretreated with traditional Chinese medicine Asarinin.
    He H; Yang T; Li F; Zhang L; Ling X
    Int Immunopharmacol; 2021 Nov; 100():108054. PubMed ID: 34492537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stromal Cells Primed by Toll-like Receptors 3 and 4 Enhanced Anti-Inflammatory Effects against LPS-Induced Macrophages via Extracellular Vesicles.
    Hwang S; Sung DK; Kim YE; Yang M; Ahn SY; Sung SI; Chang YS
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation.
    Min CK; Kim BG; Park G; Cho B; Oh IH
    Bone Marrow Transplant; 2007 May; 39(10):637-45. PubMed ID: 17369865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease.
    Fan X; Guo D; Cheung AMS; Poon ZY; Yap CS; Goh SE; Guo D; Li H; Bari S; Li S; Lim KH; Hwang WYK
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):1971-1980. PubMed ID: 29883796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
    Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD.
    Mendt M; Daher M; Basar R; Shanley M; Kumar B; Wei Inng FL; Acharya S; Shaim H; Fowlkes N; Tran JP; Gokdemir E; Uprety N; Nunez-Cortes AK; Ensley E; Mai T; Kerbauy LN; Melo-Garcia L; Lin P; Shen Y; Mohanty V; Lu J; Li S; Nandivada V; Wang J; Banerjee P; Reyes-Silva F; Liu E; Ang S; Gilbert A; Li Y; Wan X; Gu J; Zhao M; Baran N; Muniz-Feliciano L; Wilson J; Kaur I; Gagea M; Konopleva M; Marin D; Tang G; Chen K; Champlin R; Rezvani K; Shpall EJ
    Front Immunol; 2021; 12():631353. PubMed ID: 34017325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity.
    Hossain MS; Jaye DL; Pollack BP; Farris AB; Tselanyane ML; David E; Roback JD; Gewirtz AT; Waller EK
    J Immunol; 2011 Nov; 187(10):5130-40. PubMed ID: 22013117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
    Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease.
    Kim KW; Moon SJ; Park MJ; Kim BM; Kim EK; Lee SH; Lee EJ; Chung BH; Yang CW; Cho ML
    Stem Cell Res Ther; 2015 Oct; 6():202. PubMed ID: 26497134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell-derived exosomes can alleviate GVHD and preserve the GVL effect in allogeneic stem cell transplantation animal models.
    Jiang Y; Zhao J; Wang M; Huang F; Li J; Liu R; Wan J; Hao S
    Front Immunol; 2023; 14():1284936. PubMed ID: 38124750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.
    Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS
    J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
    Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization.
    Philipp D; Suhr L; Wahlers T; Choi YH; Paunel-Görgülü A
    Stem Cell Res Ther; 2018 Oct; 9(1):286. PubMed ID: 30359316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditioned medium from human palatine tonsil mesenchymal stem cells attenuates acute graft‑vs.‑host disease in mice.
    Cho KA; Kim YH; Park M; Kim HJ; Woo SY; Park JW; Ryu KH
    Mol Med Rep; 2019 Jan; 19(1):609-616. PubMed ID: 30431127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide alleviates acute graft-versus-host disease by modulating macrophage polarization.
    Liu X; Su Y; Sun X; Fu H; Huang Q; Chen Q; Mo X; Lv M; Kong Y; Xu L; Huang X; Zhang X
    Sci China Life Sci; 2020 Nov; 63(11):1744-1754. PubMed ID: 32382983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Umbilical Cord Mesenchymal Stem Cells Promote Macrophage PD-L1 Expression and Attenuate Acute Lung Injury in Mice.
    Tu C; Wang Z; Xiang E; Zhang Q; Zhang Y; Wu P; Li C; Wu D
    Curr Stem Cell Res Ther; 2022; 17(6):564-575. PubMed ID: 35086457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-γ.
    Kim DS; Jang IK; Lee MW; Ko YJ; Lee DH; Lee JW; Sung KW; Koo HH; Yoo KH
    EBioMedicine; 2018 Feb; 28():261-273. PubMed ID: 29366627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.